Michael Ohlmeyer
29Patents
5h-index
52Co-inventors
68Inventor score
Filing activity: Mar 10, 2006 → Oct 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7884109B2 | Purine and imidazopyridine derivatives for immunosuppression | Human Necessities | 55 | Active |
| US7902187B2 | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression | Chemistry; Metallurgy | 20 | Active |
| US7919490B2 | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression | Chemistry; Metallurgy | 18 | Active |
| US7807686B2 | 2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists | Chemistry; Metallurgy | 11 | Expired |
| US9540358B2 | Tricyclic compounds as anticancer agents | Chemistry; Metallurgy | 6 | Active |
| US7989459B2 | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors | Human Necessities | 4 | Active |
| US8211927B2 | 5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators | Chemistry; Metallurgy | 2 | Active |
| US9134297B2 | Method and compositions for treating cancer and related methods | Physics | 1 | Active |
| US8288371B2 | Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation | Chemistry; Metallurgy | 1 | Active |
| US9937186B2 | Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents | Chemistry; Metallurgy | 1 | Active |
| US11512052B2 | Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury | Human Necessities | 1 | Active |
| US8350043B2 | Azinone and diazinone V3 inhibitors for depression and stress disorders | Chemistry; Metallurgy | 1 | Active |
| US8895599B2 | Lipoprotein lipase-activating compositions comprising benzene derivates | Chemistry; Metallurgy | 0 | Active |
| US8314091B2 | N-benzyl,N'-arylcarbonylpiperazine derivatives | Chemistry; Metallurgy | 0 | Active |
| US7820649B2 | Quinazolinone and isoquinolinone acetamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US9494572B2 | Method and compositions for treating cancer and related methods | Physics | 0 | Active |
| US12398103B2 | 3-diarylmethylenes and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10221158B2 | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents | Chemistry; Metallurgy | 0 | Active |
| US10759790B2 | Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents | Chemistry; Metallurgy | 0 | Active |
| US10450282B2 | Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols | Emerging Cross-Sectional Technologies | 0 | Active |
| US12227479B2 | Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury | Human Necessities | 0 | Active |
| US10744141B2 | Compositions and methods for treating cancer | Human Necessities | 0 | Active |
| US9884806B2 | Cyclic vinylogous amides as bromodomain inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9937180B2 | Constrained tricyclic sulfonamides | Chemistry; Metallurgy | 0 | Active |
| US8759352B2 | 1-(4-ureidobenzoyl)piperazine derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.